BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 1
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 17
• 18
• 19
• 20
• 21
• 22
• 23
• 25
• 26
• 27
• 28
• 29
• 30

• Drug Development

  Ascletis Announces Completion of Enrollment of 120 Patients in the Phase III Clinical Trial of FASN Inhibitor ASC40 Combined with Bevacizumab for Treatment of Recurrent Glioblastoma

  Ascletis Pharma Inc. announces the completion of enrollment of 120 patients in the Phase III registration clinical trial of ASC40 combined with bevacizumab for treatment of recurrent glioblastoma.

  September 25, 2023

   · 

  3 min read
• BioCapital

  Gain Therapeutics to Participate at Cantor Fitzgerald Global Healthcare Conference 2023

  Gain Therapeutics, Inc. today announced that the Company’s Chief Executive Officer, Matthias Alder, will participate in a fireside chat and host one-on-one meetings at Cantor Fitzgerald Global Healthcare Conference taking place in New York, NY, September 26-28, 2023.

  September 25, 2023

   · 

  1 min read
• Business

  Precision Optics Corporation Schedules Fourth Quarter and Fiscal Year 2023 Conference Call for Thursday, September 28, 2023

  Precision Optics Corporation, Inc. today announced that it has scheduled a conference call to discuss fourth quarter and fiscal year 2023 financial results on Thursday, September 28, 2023.

  September 25, 2023

   · 

  3 min read
• Business

  IQVIA Appoints Richard Staub III President of Research & Development Solutions

  IQVIA™ announced it has appointed Richard Staub III, currently senior advisor to the Chairman and CEO, as president of its Research & Development Solutions business unit.

  September 25, 2023

   · 

  2 min read